000 01725 a2200481 4500
005 20250514024152.0
264 0 _c20020312
008 200203s 0 0 eng d
022 _a0969-7128
024 7 _a10.1038/sj.gt.3301627
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDaemen, T
245 0 0 _aImmunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7.
_h[electronic resource]
260 _bGene therapy
_cJan 2002
300 _a85-94 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aBlotting, Western
650 0 4 _aCancer Vaccines
_ximmunology
650 0 4 _aCell Line
650 0 4 _aCricetinae
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aFemale
650 0 4 _aGenetic Vectors
_ximmunology
650 0 4 _aImmunization
_xmethods
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aNeoplasm Transplantation
650 0 4 _aOncogene Proteins, Viral
_xgenetics
650 0 4 _aPapillomaviridae
_xgenetics
650 0 4 _aPapillomavirus E7 Proteins
650 0 4 _aPapillomavirus Infections
_xcomplications
650 0 4 _aRepressor Proteins
650 0 4 _aSemliki forest virus
_xgenetics
650 0 4 _aT-Lymphocytes, Cytotoxic
_ximmunology
650 0 4 _aTumor Virus Infections
_xcomplications
650 0 4 _aUterine Cervical Neoplasms
_xprevention & control
700 1 _aRegts, J
700 1 _aHoltrop, M
700 1 _aWilschut, J
773 0 _tGene therapy
_gvol. 9
_gno. 2
_gp. 85-94
856 4 0 _uhttps://doi.org/10.1038/sj.gt.3301627
_zAvailable from publisher's website
999 _c11765258
_d11765258